Although evidence of association with breast cancer risk was observed for the above-described loci in BRCA1 and BRCA2 mutation carriers, none of these associations reached significance after a Bonferroni adjustment for multiple testing. This evidence concerns the gene BRCA2 and breast carcinoma.